A randomized clinical trial of unfractioned heparin for treatment of sepsis (the HETRASE study): design and rationale [NCT00100308]

INTRODUCTION: Infection promotes coagulation via a large number of molecular and cellular mechanisms, and this procoagulant activity has boosted basic and clinical research using anticoagulant molecules as therapeutic tools in sepsis. Heparin, which is a naturally occurring proteoglycan that acts by...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaimes, Fabián, De La Rosa, Gisela, Arango, Clara, Fortich, Fernando, Morales, Carlos, Aguirre, Daniel, Patiño, Pablo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482716/
https://www.ncbi.nlm.nih.gov/pubmed/16729879
http://dx.doi.org/10.1186/1745-6215-7-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482716/
https://www.ncbi.nlm.nih.gov/pubmed/16729879
http://dx.doi.org/10.1186/1745-6215-7-19

Ejemplares similares